img
img
Do elevated plasma S100A12 levels predict atherosclerosis in peritoneal dialysis patients?   
Yazarlar (11)
Özlem Yayar
Türkiye
Barış Eser
Hitit Üniversitesi, Türkiye
Mehmet Büyükbakkal
Türkiye
Bülent Erdoğan
Türkiye
Zafer Ercan
Türkiye
Özgür Merhametsiz
Türkiye
Ayhan Haspulat
Türkiye
Alaattin Kali
Türkiye
Tolga Yıldırım
Hacettepe Üniversitesi, Türkiye
Prof. Dr. Başol CANBAKAN Prof. Dr. Başol CANBAKAN
Kafkas Üniversitesi, Türkiye
Mehmet Deniz Aylı
Sağlık Bilimleri Üniversitesi, Türkiye
Devamını Göster
Özet

Aim

Atherosclerotic cardiovascular disease is one of the major causes of mortality and morbidity in peritoneal dialysis (PD) patients. S100A12 is an endogenous receptor ligand of advanced glycation end-products. It was shown to contribute to the development of atherosclerosis in animal models. The aim of this study was to evaluate the relationship between S100A12 levels and carotid atherosclerosis in PD patients.

Methods

A cross-sectional study was performed in 56 PD patients and 20 control subjects. Plasma S100A12 levels were measured from all participants beside routine laboratory evaluation. All subjects underwent high-resolution B-mode ultrasonography to determine carotid intima media thickness (CIMT). S100A12 levels were compared between patient and control groups. Correlation analyses of S100A12 with other laboratory values and CIMT were also performed.

Results

Plasma S100A12 levels were higher in PD patients compared with control subjects (129.5 ± 167.2 ng/mL vs. 48.5 ± 30.3 ng/mL, respectively, p < 0.001). In the patient group, CIMT was found to be positively correlated with age (r = 0.354; p = 0.007), CRP level (r = 0.269; p = 0.045), and S100A12 (r = 0.293; p = 0.028) level while it was found to be negatively correlated with hemoglobin concentration (r = -0.264; p = 0.049). In the linear regression analysis, the model, including CRP, S100A12, age, and Hgb, was found to be significant (F: 4.177, p: 0.005). When the parameters are analyzed age and S100A12 were found to be independent determinants of CIMT (β = 0.308, p = 0.018 and β = 0.248, p = 0.049, respectively).

Conclusions

This study suggests that an elevated plasma S100A12 level was closely associated with atherosclerosis. With aging elevated plasma S100A12 may show a powerful proatherogenic potential in patients undergoing PD.
Anahtar Kelimeler
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Renal Failure
Dergi ISSN 0886-022X Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce
Basım Tarihi 02-2015
Cilt No 37
Sayı 5
Sayfalar 845 / 850
Doi Numarası 10.3109/0886022X.2015.1033633
Makale Linki http://www.tandfonline.com/doi/full/10.3109/0886022X.2015.1033633
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Do elevated plasma S100A12 levels predict atherosclerosis in peritoneal dialysis patients?

Paylaş